BDBM444577 US10662186, Compound 97::US10988476, Compound I-98

SMILES Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN=C(N)N)C5)ncc3F)cc2n1C(C)C

InChI Key InChIKey=HCRISSWRQLLFKO-UHFFFAOYSA-N

Data  10 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 444577   

TargetCyclin-dependent kinase 4(Human)
Shanghai Pharmaceuticals Holding

US Patent
LigandChemical structure of BindingDB Monomer ID 444577BDBM444577(US10662186, Compound 97 | US10988476, Compound I-9...)
Affinity DataIC50: 1.04nMAssay Description:1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 4(Human)
Shanghai Pharmaceuticals Holding

US Patent
LigandChemical structure of BindingDB Monomer ID 444577BDBM444577(US10662186, Compound 97 | US10988476, Compound I-9...)
Affinity DataIC50: 1.73nMAssay Description:1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 6(Human)
Shanghai Pharmaceuticals Holding

US Patent
LigandChemical structure of BindingDB Monomer ID 444577BDBM444577(US10662186, Compound 97 | US10988476, Compound I-9...)
Affinity DataIC50: 2.11nMAssay Description:1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 6(Human)
Shanghai Pharmaceuticals Holding

US Patent
LigandChemical structure of BindingDB Monomer ID 444577BDBM444577(US10662186, Compound 97 | US10988476, Compound I-9...)
Affinity DataIC50: 5.01nMAssay Description:1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 2(Human)
Shanghai Pharmaceuticals Holding

US Patent
LigandChemical structure of BindingDB Monomer ID 444577BDBM444577(US10662186, Compound 97 | US10988476, Compound I-9...)
Affinity DataIC50: 15nMAssay Description:1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 9(Human)
Shanghai Pharmaceuticals Holding

US Patent
LigandChemical structure of BindingDB Monomer ID 444577BDBM444577(US10662186, Compound 97 | US10988476, Compound I-9...)
Affinity DataIC50: 127nMAssay Description:1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 5(Human)
Shanghai Pharmaceuticals Holding

US Patent
LigandChemical structure of BindingDB Monomer ID 444577BDBM444577(US10662186, Compound 97 | US10988476, Compound I-9...)
Affinity DataIC50: 288nMAssay Description:1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Shanghai Pharmaceuticals Holding

US Patent
LigandChemical structure of BindingDB Monomer ID 444577BDBM444577(US10662186, Compound 97 | US10988476, Compound I-9...)
Affinity DataIC50: 670nMAssay Description:1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 2(Human)
Shanghai Pharmaceuticals Holding

US Patent
LigandChemical structure of BindingDB Monomer ID 444577BDBM444577(US10662186, Compound 97 | US10988476, Compound I-9...)
Affinity DataIC50: 670nMAssay Description:1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 1(Human)
Shanghai Pharmaceuticals Holding

US Patent
LigandChemical structure of BindingDB Monomer ID 444577BDBM444577(US10662186, Compound 97 | US10988476, Compound I-9...)
Affinity DataIC50: 1.70E+3nMAssay Description:1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent